Biotech Companies
Explore 3 Biotech companies in our AI directory. Leading companies include Recursion Pharmaceuticals, Xaira Therapeutics, Biome Makers.
Recursion Pharmaceuticals
Salt Lake City, United States
Recursion Pharmaceuticals leverages extensive biological and chemical datasets – exceeding 65 petabytes encompassing phenomics, transcriptomics, and patient data – to power its Recursion OS drug discovery platform. This platform utilizes computer vision, machine learning, and a proprietary supercomputer, BioHive-2, to analyze cellular images and predict drug efficacy, significantly accelerating hit identification and IND-enabling studies. Currently, Recursion is advancing a pipeline of potential therapies, including REC-3565 for B-cell lymphomas which is in Phase 1 clinical trials, and has established strategic partnerships with pharmaceutical and technology leaders to expand its AI-driven drug discovery capabilities.
Xaira Therapeutics
San Francisco, United States
Xaira Therapeutics is building a generative AI platform focused on de novo protein design and drug candidate creation, leveraging advancements from the technology behind AlphaFold. The company’s core innovation lies in applying AI to not just predict protein structures, but to generate novel protein therapeutics with optimized properties for a range of diseases. Backed by a $1 billion Series A funding round, Xaira Therapeutics aims to accelerate drug discovery beyond traditional methods and is initially focusing on developing therapeutics for currently undruggable targets.
Biome Makers
Valencia, Spain
Biome Makers uses AI and DNA sequencing to analyze soil microbiomes, helping farmers optimize crop yields and reduce chemical inputs.